Original Papers - Andrology
Vol. 97 No. 4 (2025)
https://doi.org/10.4081/aiua.2025.14297
Multifactorial analysis of male infertility: sperm DNA damage, semen parameters, and genetic testing in Iranian infertile men
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 1 September 2025
Accepted: 25 September 2025
Published: 24 December 2025
Accepted: 25 September 2025
Published: 24 December 2025
461
Views
224
Downloads
Introduction: Male infertility is a multifactorial condition influenced by genetic, physiological, and environmental factors. While semen analysis is the cornerstone of diagnosis, additional tests like sperm DNA fragmentation (DFI) assessment and genetic testing are increasingly recognized for their diagnostic and prognostic value. This study investigates the relationships between DFI, semen parameters, and genetic abnormalities in Iranian men.
Methods: A retrospective cross-sectional study analyzed 6,397 men (5,196 infertile and 1,201 fertile controls) at the MOM Infertility Center between December 2022 and August 2023. Semen analysis evaluated sperm concentration, motility, morphology, Y chromosome AZF microdeletion testing, and whole-exome sequencing (WES) on subsets of infertile men. Correlations between age, sperm parameters, and DFI were assessed, and logistic regression evaluated the likelihood of abnormal sperm conditions.
Results: Infertile men showed significantly lower sperm concentration, motility, and morphology, along with higher DFI, compared to controls. DFI was negatively correlated with sperm concentration, motility, and morphology. Age was positively correlated with DFI and negatively correlated with motility and morphology. Genetic abnormalities, including chromosomal anomalies, AZF deletions, and WES-detected mutations, were identified in subsets of infertile men, underscoring the value of genetic testing.
Conclusions: This study highlights significant associations between DFI, age, semen parameters, and genetic abnormalities in male infertility. Incorporating advanced diagnostic tools, such as DFI assessment and genetic testing, into clinical practice can improve diagnostic accuracy and guide personalized treatment strategies for infertile men.
Downloads
Download data is not yet available.
1. Mehta A, Nangia AK, Dupree JM, Smith JF. Limitations and barriers in access to care for male factor infertility. Fertil Steril. 2016;105:1128-1137.
2. Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:1-9.
3. Corsini C, Santi D, Fava G, et al. Is there a relevant clinical impact in differentiating idiopathic versus unexplained male infertility? World J Mens Health. 2022; 41:354.
4. Wyrwoll MJ, Rudnik-Schöneborn S, Tüttelmann F. Genetic counseling and diagnostic guidelines for couples with infertility and/or recurrent miscarriage. Med Genet. 2021; 33:3-12.
5. Barati E, Nikzad H, Karimian M. Oxidative stress and male infertility: current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell Mol Life Sci. 2020; 77:93-113.
6. Gunes S, Al-Sadaan M, Agarwal A. Spermatogenesis, DNA damage and DNA repair mechanisms in male infertility. Reprod Biomed Online. 2015; 31:309-319.
7. Torres-Flores U, Hernández-Hernández A. The interplay between replacement and retention of histones in the sperm genome. Front Genet. 2020; 11:780.
8. Sharma P, Agarwal A, Gupta S, et al. Oxidative stress-induced apoptosis and autophagy: balancing the contrary forces in spermatogenesis. Biochim Biophys Acta. 2023; 1869:166742.
9. Sharma R, Harlev A, Agarwal A, Esteves SC. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 WHO laboratory methods. Eur Urol. 2016; 70:635-645.
10. Durairajanayagam D. Lifestyle causes of male infertility. Arab J Urol. 2018;16:10-20.
11. Salas-Huetos A, Bulló M, Salas-Salvadó J. Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review. Hum Reprod Update. 2017; 23:371-389.
12. Agarwal A, Majzoub A, Baskaran S, et al. Sperm DNA fragmentation: a new guideline for clinicians. World J Mens Health.
2020; 38:412. 13. Sciarra F, Salacone P, Mazzilli R, et al. Incidence of Y chromosome microdeletions in patients with Klinefelter syndrome. J Endocrinol Invest. 2019; 42:833-842.
14. Deng CY, Zhang Y, Li Y, et al. Microdeletions and vertical transmission of the Y-chromosome azoospermia factor region. Asian J Androl. 2023; 25:5-12.
15. Elsaid HOA, Ahmed MA, Elhussein AM, et al. Detection of AZF microdeletions and reproductive hormonal profile analysis of infertile Sudanese men. BMC Urol. 2021; 21:69.
16. Masvidal L, Casals T, Ramos MD, et al. The p.Arg258Gly mutation in intracellular loop 2 of CFTR is associated with CFTR-related disorders. Genet Test Mol Biomarkers. 2009; 13:765-768.
17. Skowronek MF, Paredes R, Rivas F, et al. Associations between male infertility and ancestry in South Americans: a case control study. BMC Med Genet. 2017; 18:1-10.
18. Krausz C, Riera-Escamilla A. Genetics of male infertility. Emery Rimoin Genet Genomics. 2022; 121-147.
19. Oud MS, Volozonoka L, Smits RM, et al. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019; 34:932-941.
20. Tüttelmann F, Ruckert C, Röpke A. Disorders of spermatogenesis: perspectives for novel genetic diagnostics. Med Genet. 2018;30:12-20.
21. Houston BJ, Riera-Escamilla A, Wyrwoll MJ, et al. A systematic review of the validated monogenic causes of human male infertility: 2020 update. Hum Reprod Update. 2022; 28:15-29.
22. Liu K, Zhao Y, Li Y, et al. Correlation analysis of sperm DNA fragmentation index with semen parameters and ART outcomes. Sci Rep. 2023; 13:2717.
23. Gamage TK, Chamley LW, James JL. Stem cell insights into human trophoblast lineage differentiation. Hum Reprod Update. 2017; 23:77-103.
24. López G, Lafuente R, Checa MA, et al. Diagnostic value of sperm DNA fragmentation and sperm high-magnification for predicting ART outcome. Asian J Androl. 2013; 15:790.
25. Pelzman DL, Hwang K. Genetic testing for men with infertility: techniques and indications. Transl Androl Urol. 2021; 10:1354-1364.
26. Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015; 10:1556-1566.
27. Miller DT, Lee K, Chung WK, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing. Genet Med. 2021; 23:1381-1390.
28. Osadchuk L, Osadchuk A. Individual lifestyle and male fertility. Hum Physiol. 2023; 49:196-207.
29. Li F, Zhang Y, Wang L, et al. Sperm DNA fragmentation index affect pregnancy outcomes and offspring safety in ART. Sci Rep. 2024; 14:356.
30. Guo LY, Zhang Y, Liu Y, et al. Male age is more critical to sperm DNA integrity than routine semen parameters. Andrologia. 2020;52:e13449.
31. Caliskan Z, Yildiz C, Yildirim ME, et al. Evaluation of sperm DNA fragmentation in male infertility. Andrologia. 2022;54:e14587.
32. Campos LGA, Silva J, Oliveira R, et al. Correlation between sperm DNA fragmentation index and semen parameters in 418 men. JBRA Assist Reprod. 2021; 25:349.
33. Ferrigno A, Bertagna A, Rago R, et al. Correlation between the DNA fragmentation index and sperm morphology of infertile patients. J Assist Reprod Genet. 2021; 38:979-986.
34. Maghsoudlou S, Tavafian SS, Montazeri A, et al. Consanguineous marriage, maternal characteristics and stillbirth risk: a case-control study. Acta Obstet Gynecol Scand. 2015;94:1095-1101.
35. Abdulrazzaq Y, Bener A, Al-Gazali LI, et al. A study of possible deleterious effects of consanguinity. Clin Genet. 1997; 51:167-173.
36. Bittles AH, Grant JC, Sullivan SG, Hussain R. Does inbreeding lead to decreased human fertility? Ann Hum Biol. 2002; 29:111-130.
37. Yahaya TO, Olayemi FO, Adebayo O, et al. Genes predisposing to syndromic and nonsyndromic infertility: a narrative review. Egypt J Med Hum Genet. 2020; 21:1-17.
38. Yahaya TO, Olayemi FO, Adebayo O, et al. Chromosomal abnormalities predisposing to infertility: testing and management. Bull Natl Res Cent. 2021; 45:1-15.
39. Okutman O, Gunes S, Inan C, et al. Genetic evaluation of patients with non-syndromic male infertility. J Assist Reprod Genet. 2018; 35:1939-1951.
40. Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl. 2012; 14:32.
41. Vicdan A, Akarsu C, Sozen E, et al. Genetic aspects of human male infertility: chromosomal abnormalities and Y chromosome microdeletions. Eur J Obstet Gynecol Reprod Biol. 2004; 117:49-54.
42. Abbaspour S, Ghasemi N, Ghasemi M, et al. Prevalence of chromosomal abnormalities in Iranian patients with infertility. Arch Iran Med. 2023; 26:110.
43. Krausz C, Hoefsloot L, Simoni M, Tüttelmann F, et al. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology. 2014; 2:5-19.
44. Simoni M, Gromoll J, Tüttelmann F, et al. Clinical consequences of microdeletions of the Y chromosome: the extended Münster experience. Reprod Biomed Online. 2008; 16:289-303.
45. Lo Giacco D, Chianese C, Ars E, et al. Clinical relevance of Ylinked CNV screening in male infertility: insights from 8-year experience of a diagnostic genetic lab. Eur J Hum Genet. 2014; 22:754-761.
46. Yousefi-Razin E, Nasiri MJ, Omrani MD. Frequency of Y chromosome microdeletions among Iranian infertile men with azoospermia and severe oligozoospermia: a meta-analysis. J Reprod Infertil. 2016; 17:208.
47. Akbarzadeh Khiavi M, Ghasemzadeh A, Ghasemi M, et al. Karyotypic abnormalities and molecular analysis of Y chromosome microdeletion in Iranian Azeri Turkish infertile men. Syst Biol Reprod Med. 2020; 66:140-146.
48. Guerri G, Krausz C, Forti G, et al. Non-syndromic monogenic male infertility. Acta Biomed. 2019;90:S62.
49. Arafat M, Har-Vardi I, Abdallah J, et al. Mutation in TDRD9 causes non-obstructive azoospermia in infertile men. J Med Genet. 2017; 54:633-639.
50. Wu H, Wang Y, Li Z, et al. Novel CFAP43 and CFAP44 mutations cause male infertility with multiple morphological abnormalities of the sperm flagella. Reprod Biomed Online. 2019; 38:769-778.
51. Nsota Mbango JF, Martinez G, Coutton C, et al. Genetic causes of male infertility: snapshot on morphological abnormalities of the sperm flagellum. Basic Clin Androl. 2019; 29:2.
52. Tan C, Zhang Y, Wang Y, et al. Bi-allelic variants in DNHD1 cause flagellar axoneme defects and asthenoteratozoospermia in humans and mice. Am J Hum Genet. 2022; 109:157-171.
53. Martinez G, Nsota Mbango JF, Coutton C, et al. New mutations in DNHD1 cause multiple morphological abnormalities of the sperm flagella. Int J Mol Sci. 2023; 24:2559.
54. Precone V, Stuppia L, Gatta V, et al. Male infertility diagnosis: improvement of genetic analysis performance by pre-diagnostic genes in a custom NGS panel. Front Endocrinol. 2021; 11:605237.
55. Pereira R, Oliveira J, Silva J, et al. Mutation analysis in patients with total sperm immotility. J Assist Reprod Genet. 2015; 32:893-902.
56. Zuccarello D, Ferlin A, Garolla A, et al. Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. Hum Reprod. 2008; 23:1957-1962.
57. Levkova M, Radanova M, Angelova L. Potential role of dyneinrelated genes in male infertility: a systematic review and meta-analysis. Andrology. 2022; 10:1484-1499.
58. Fassad MR, Patel MP, Shoemark A, et al. Mutations in DNAH9 cause motile cilia defects and situs inversus. Am J Hum Genet. 2018;103:984-994.
59. Lucas JS, Davis SD, Omran H. Static respiratory cilia associated with mutations in DNAH11: a mouse model of PCD. Hum Mutat. 2012; 33:495-503.
60. Zhang J, Shen Y, Wang Y, et al. Loss of DRC1 function leads to sperm flagella abnormalities and male infertility. Hum Mol Genet. 2021; 30:1996-2011.
61. Wirschell M, Olbrich H, Werner C, et al. DRC1 is essential for motile cilia function in algae and humans. Nat Genet. 2013; 45:262-268.
62. Kamel A, El-Baz M, El-Gayar D, et al. DNAH5 gene and its correlation with linc02220 expression and sperm characteristics. Mol Biol Rep. 2022; 49:9365-9372.
63. Knowles MR, Leigh MW, Carson JL, et al. Mutations of DNAH11 in primary ciliary dyskinesia with normal ultrastructure. Thorax 2012; 67:433-441.
64. Zietkiewicz E, Bukowy-Bieryllo Z, Dme´nska H, et al. CFAP300: mutations in Slavic patients with PCD and role in dynein arms trafficking. Am J Respir Cell Mol Biol. 2019; 61:440-449.
65. Morimoto Y, Matsumoto K, Ohtsuka Y, et al. Nonsense mutation in CFAP43 causes hydrocephalus with ciliary abnormalities. Neurology. 2019; 92:e2364-e2374.
66. Moon KH, Kim HJ, Lee JH, et al. Dysregulation of sonic hedgehog signaling causes hearing loss in ciliopathy mouse models. Elife 2020; 9:e56551.
67. Fassad MR, Patel MP, Shoemark A, et al. Defective airway intraflagellar transport in ciliopathy syndrome caused by IFT74 mutations. Hum Mol Genet. 2023;32:3090-3104.
68. Stallmeyer B, Reuter MS, Schmidts M, et al. Inherited defects of piRNA biogenesis cause transposon de-repression and male infertility. Nat Commun. 2024;15:6637.
69. Duriez B, Duquesnoy P, Escudier E, et al. A common variant and nonsense mutation in thioredoxin family causes PCD. P Natl Acad Sci USA 2007;104:3336-3341.
70. Sadek CM, Jimenez A, Damdimopoulos AE, et al. Sptrx-2, a fusion protein with thioredoxin and NDP-kinase domains, is expressed in human testis germ cells. Genes Cells. 2001; 6:1077-1090.
71. Mou L, Wang Y, Li Z, et al. A dominant-negative mutation of HSF2 associated with idiopathic azoospermia. Hum Genet. 2013;132:159-165.
72. Zhao H, Zhang Y, Li Z, et al. Case report: non-obstructive azoospermia with heat shock factor-2 mutation. Medicine (Baltimore). 2020; 99:e21107.
73. Bombieri C, Claustres M, De Boeck K, et al. Recommendations for classification of CFTR-related disorders. J Cyst Fibros. 2011;10:S86-S102.
74. Bieniek JM, Lapin CD, Jarvi KA. Genetics of CFTR and male infertility. Transl Androl Urol. 2021; 10:1391.
75. van der Ven K, Engels H, Veldhuis JD, et al. CF mutation screening in healthy men with reduced sperm quality. Hum Reprod. 1996;11:513-517.
76. Wyrwoll M, Pohl E, Wiesner T, et al. Bi-allelic variants in MSH4 and MSH5 cause infertility in both sexes. Hum Reprod. 2022;37:178-189.
77. Chen M, Zhang Y, Li Z, et al. Mutations of MSH5 in NOA and rescue via in vivo gene editing. Signal Transduct Target Ther. 2022; 7:1.
78. Han XX, Zhang Y, Li Z, et al. Development of precocious puberty in children: medicinal plant treatment. Biomed Pharmacother. 2022; 156:113907.
79. Behvarz M, Ghasemi M, Yousefi-Razin E, et al. Correlation between LHCGR and NR5A1 polymorphism and male infertility risk. Actas Urol Esp (Engl Ed). 2024;48:246-253.
80. Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, et al. CYP21 mutation analysis in 198 patients with 21-hydroxylase deficiency: six novel mutations. J Clin Endocrinol Metab. 2003; 88:3852-3859.
81. Espinosa Reyes TM, García Rodríguez M, Pérez López R, et al. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. BMC Endocr Disord. 2020; 20:1-8.
82. Gangodkar P, Joshi M, Desai M, et al. NGS assay for CYP21A2 gene in 310 cases of congenital adrenal hyperplasia. Endocrine. 2021; 71:189-198.
83. Gao Y, Zhang Y, Li Z, et al. Prevalence of heterozygous CYP21A2 deficiency in idiopathic acne and hirsutism. Endocrine. 2020;67:665-672.
84. New MI, Wilson RC, Merke DP, et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Genetic Steroid Disorders 2023; 35-61.
85. Carmina E. Reproductive dysfunction in classical and nonclassical congenital adrenal hyperplasia. In: Fertility and Reproductive Outcomes in CAH. 2021; 93-97.
86. Qiao J, Han B. Diseases caused by mutations in LH/CG receptor. Prog Mol Biol Transl Sci. 2019; 161:69-89.
87. Katsanis N, Beales PL, Woods MO, et al. BBS4 is a minor contributor to Bardet-Biedl syndrome and may participate in triallelic inheritance. Am J Hum Genet. 2002;71:22-29.
88. Priya S, Nampoothiri S, Sen P, et al. Bardet-Biedl syndrome: genetics, molecular pathophysiology, and management. Indian J Ophthalmol. 2016; 64:620-627.
Supporting Agencies
MOM Fertility and Infertility Center, Tehran, IranHow to Cite
Multifactorial analysis of male infertility: sperm DNA damage, semen parameters, and genetic testing in Iranian infertile men. (2025). Archivio Italiano Di Urologia E Andrologia, 97(4). https://doi.org/10.4081/aiua.2025.14297
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.